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The pervasiveness of human health impacts and ecosystem effects of lead (Pb) is not controversial, but 
there are serious arguments about the pace at which Pb should be eliminated from consumer products.  
Presumably, these arguments can be resolved by converting costs and benefits of Pb use to similar 
units, a notorious methodological challenge for health impacts in developing countries. To estimate the 
costs of Pb poisoning attributable to petrochemicals in Nigeria, we conducted a meta-analysis of 
measured blood lead levels (BLL) and we used published Relative Risk values for disease categories to 
estimate the proportion of overall disease burden attributable to Pb. We modeled the health costs of Pb 
exposure and we compared this to the cost of banning Pb. We estimate that Pb exposure accounts for 7 
- 25% of the disease burden among Nigerian children, costing the health and education sectors $0.38 – 
1.15 billion year-1 for every 1 µg/dL increase in BLL.  In comparison, we estimate that a Pb abatement 
program in Nigeria will cost $0.076 – 0.23 billion year-1. If a Pb phase-out program is instituted now to 
lower the national BLL to 1 µg/dL by 2020, a savings of $2.7-8.0 billion would be realized.  
 





Exposure to Pb is widely recognized as a major risk 
factor for several human diseases, and the structure of 
industrial ecological systems have made exposure to Pb 
unavoidable for most people alive today (Needleman, 
1999; Pruss-Ustun et al., 2004; WHO, 2000). In affluent 
countries, sizable investments in the implementation of 
environmental policies prohibiting the addition of Pb to 
many consumer products have resulted in rapid decline 
of human exposures, demonstrable by observed reduc-
tions in the human blood content of Pb (USEPA, 1985; 
Grosse et al., 2002). Unfortunately, the public health 
gains from extensive research on the adverse effects of 
Pb and the remarkable successes of effective policies in 
these industrialized countries have not yet enveloped 
developing countries, and the course of gasoline-fueled 
industrialization remains hazardous to public health 
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Children throughout Africa are particularly vulnerable to 
Pb exposure because of unabated use of leaded gasoline 
and lead-acid batteries in automobiles (Nriagu et al., 
1996 and 1997; Omokhodion, 1994), and recently, unre-
gulated cottage industries associated electronic waste 
recycling (Lincoln et al., 2007). Particular socio-ecological 
and climatic factors also contribute to high levels of 
inhalation and ingestion of Pb-laden aerosol and dust 
(Laidlaw et al., 2005; Ogunfowokan et al., 2004; Ogun-
sola et al., 1994; Rankin et al., 2005). Despite the 
initiation of phase-out programs in a few countries, the 
gasoline sold in most African countries contains 0.5 - 0.8 
g/l lead, the highest levels in the world (Thomas, 1995).  
In Nigeria, gasoline with average Pb content of 0.66 g L-1 
remains in use (Fakayode and Olu-Owolabi, 2003).  In 
Nigeria’s largest city of Lagos, specific emissions of lead 
exceed 164 kg km-2 representing approximately 20% of 
the 2.46 Gg of lead emissions nationwide (Obioh et al., 
1988), and ambient air concentration of Pb ranges up to 
9.58 µg m3, exceeding WHO recommended annual ave-
rage of 0.5 µg m3 at all locations (Obioh et al., 2005).  
Furthermore, mean blood lead levels (BPb) measured at  
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various times and urban locations in Nigeria have ranged 
from 11.4 – 25 µg dL-1; far exceeding the 10 µg dL-1 act-
ion dose recommended for the U.S. population (Adeba-
mowo et al., 2006; Ademuyiwa et al., 2005; Nriagu et al., 
1997).   
In addition to automotive and industrial sources, eleva-
ted blood lead levels in children have been attributed to 
paint, household dust, overcrowding and low parental 
income (Charney, 1982; Kapu et al., 1989; Kristensen et 
al., 1993; Landrigan et al., 1976; Nriagu and Pacnya, 
1988). Previous studies in Africa have also shown that 
one of the strongest indicators of childhood BPb was the 
family either owning a car or living in a house located on 
a tarred road (Nriagu et al., 1996). These factors are 
typically only encountered in urban centers. However, the 
geochemical behavior of Pb and its association with sus-
pended particulates suggests that children in remote 
suburban or rural regions may also suffer from Pb expo-
sure, in which case, the adverse affects of Pb should be 
widespread. This hypothesis has not been rigorously tes-
ted within the African continent. Also, it has been rela-
tively simple to quantify the financial costs associated 
with Pb-phase out programs, but the economic costs of 
health effects attributable to lead exposure are typically 
externalized. This has made it difficult for policymakers to 
comprehend cost-benefit scenarios used to justify lead 
abatement programs. 
The goal of this research is to provide cost-benefit 
information to environmental policy makers in Nigeria by 
employing a quantitative comparison of the health cost of 
lead-related disease burden to the cost of a national lead 
abatement program. There are three research objectives: 
(1) the determination of the representative blood-lead 
content of Nigerian children (ages 1 - 6 yrs.) and subse-
quent contribution of environmental lead exposure to the 
burden of disease in Nigeria; (2) the estimation of the 
health costs of environmental lead exposure in Nigeria; 
(3) and the estimation of the cost of a national lead-





Assessment of lead exposure 
 
Children (ages 1 – 6 years; N = 306) were recruited for this study 
through the scheduled immunization clinic in the semi-rural region 
of Otukpo, Nigeria (total population of approximately 136,800 
people, of which 45% are younger than 14 years for the study 
period (Population Reference Bureau, 2006). Blood lead concen-
trations were determined by means of an automatic blood lead 
analyzer with a sensitivity range of 1.4 - 65 µg dL-1 based on blood 
sample volume of 50 µl (LeadCare, ESA Inc., Chelmsford, MA and 
AndCare Inc., Durham, NC.  The equipment was kindly provided by 
the U.S. Centers for Disease Control and Prevention, Atlanta, 
Georgia). The necessary size of the population sample was esti-
mated within the desired margin of error for predicting the popu-

























= 300  
 
where:    
Z = z-score (2.96, 99% CI) ; s = standard deviation (3.8 µg dL-1; 
Nriagu et al., 1996); m = desired margin of error (± 0.65 µg dL-1) 
Informed consent was obtained for all human subjects according 
to standard research ethics, and as approved by the Institutional 
Review Board. Exclusion categories included those previously 
treated for Pb poisoning, those who had not been living in the same 
residence for at least the past 6 months, those who are being 
treated for severe illness, and those not accompanied by a legal 
guardian. In addition to the determination of BPb concentrations, a 
questionnaire was completed by each child subject with the legal 
guardian to record demographic and socioeconomic statistics and 
to assess predictors of Pb exposure and the predominant pathways 
for such exposures. The questionnaire survey was modified from 
the standard instrument used by U.S. Center for Disease Control 
and Prevention to better capture the social, economic, and cultural 
environment of Nigeria. With written consent, the nurse/phleboto-
mist administered the survey and offered the subject a fact sheet 
containing health information on lead exposure in children.   
 
 
Association of lead exposure and disease burden 
 
Lead exposure is implicated in several disease burden categories 
including systemic effects such as hypertension, gastrointestinal 
effects, anemia, nephropathy, and nervous system effects such as 
Intelligence Quotient (IQ) defects and encephalopathy (ATSDR, 
1999; Schwartz, 1991, 1993, 1994; Schwartz et al., 1986). We 
estimated the contribution of Pb exposure to the following disease 
categories in Nigeria: genito-urinary disease, prematurity, dental 
caries, nervous system cancers, congenital anomalies, hyperten-
sion, cerebrovascular disease, low birth weight, and mild mental 
retardation (MMR; IQ levels 50-69). Nine of the 106 disease cate-
gories included in the World Health Organization’s Global Burden of 
Disease study were included in this study (Murray and Lopez, 1996; 
but see Cooper et al., 1998). A population-adjusted, disease burden 
for Nigeria was estimated from the regional burdens for relative risk 
analysis. The numerical model DISMOD® was used to estimate 
disease burden for two disease categories that were not included in 
the GBD, prematurity and mild mental retardation (http://www.hs-
ph.harvard.edu/organizations/bdu/DisMod.html). 
    Our estimate of Pb-associated MMR presented a special cha-
llenge. Pruss-Ustun et al. (2004) estimated the prevalence of men-
tal retardation and cognitive impairment from known, non-congeni-
tal causes (those mentioned above), compared values of developed 
and developing countries, and estimated a rate accounting for the 








Where: MR = mental retardation; PR = region-specific prevalence of 
MR from known causes; Pbaseline = prevalence of MR from known, 
non-congenital causes in developed countries; PMR standard = 
prevalence of MR according to the standard distribution of IQ score; 
AR = adjustment ratio 
That lead exposure contributes to IQ deficit is universally accep-
ted, but there is no consensus on the dose response relationship 







Table 1. Variables for the cost of lead abatement in Nigeria. 
 







































Lynn and Vanhanen, 2002; Stouthard et al., 1997).  Based on the 
meta-analysis conducted by Popcock et al. (1994) and by Schwartz 
(1994), we relied on the following categories defined by three levels 
of exposure to Pb measured by blood Pb content. Children with 
relatively low BLLs (5 - 8 µg/dL) suffer a 1.0 IQ deficit; those with 
medium BLL (9 - 15 µg/dL) suffer 2.0 IQ deficits, and children in the 
high Pb exposure category (> 16 µg/dL) suffer 3.0 IQ deficit. 
Pruss-Ustun et al. (2004) estimated lead-induced MMR to be 
0.385/1000 for Sub-Saharan Africa (SSA) populations, compared to 
0.256 per 100 people in Europe. We judged this estimate to be 
inadequate for Nigeria based on the assumption of global average 
IQ score of 100.  Instead, we relied on the baseline IQ estimates of 
Lynn and Vanhanen (2002) that are more localized in perspective, 
providing average IQ scores for SSA and Nigeria as 70 and 67, 
respectively. The present study also departs from the Pruss-Ustun 
et al. (2004) assessment in the following way. Instead of extracting 
the fraction of lead-induced MMR from an overall MMR rate in 
Nigeria, an estimation of the IQ drop due exclusively to lead 
exposure was assessed on the basis of the range of measured 
BLLs and the IQ decrements attributed to those ranges in the 
clinical literature. To estimate the burden attributable to MMR, we 
adopted the approach used in a Dutch Burden of Disease Study 
where a severity weight of 0.06 was assigned for deficits in IQ 
between 1 - 4 points (Stouthard et al., 1997).   
The proportion of disease cases attributable to Pb exposure to an 
environmental risk factor (Attributable Faction) was based on 













where: =jAF the fraction of burden from some cause j (lead 
exposure); =jRR the relative risk of disease for cause j in the 
exposed to unexposed group; P = Prevalence of exposure. 
The attributable fraction was used to derive an estimate of the 
Lead Attributable Burden (LABD) for low, medium, and high Pb ex-
posures given Relative Risks (or Odds Ratios) for each cause of 
death and disability related to the exposure, levels of exposure (pre 

















% > 10 
ug/dL 
Female 138 8.9 (2.1,23.8) 4.2 32.5 
Male 168 9.8 (2.2,31.8) 4.8 35.0 




valence), and burden of disease due to each cause of death and 
disability in a given population: 
 
AB = AFjB j  
 
where: AB = Attributable Burden for a risk factor; AFj  = Fraction of 
Burden from cause j 
Bj = population level burden of cause j 
 
 
Economic cost of lead exposure 
 
The U.S. EPA estimated the cost of a lead abatement program to 
be approximately 500 million dollars per year in 1985 (USEPA 
1985). Estimates for the cost of a lead additive (Tetraethyl lead 
(TEL), $0.002/liter), refinery overhaul ($0.006/liter), and non-lead 
additive (Methy tert butyl ether (MTBE), $0.01/liter) were derived 
from Thomas and Kwong (2000). The average cost of gasoline in 
Nigeria was estimated to be approximately $.16/liter (Obioh et al., 
2005). The annual consumption of domestic and imported gasoline 
in Nigeria is 24,260 and 93,550 barrels per day, respectively (US 
DoE, 2000). Thus, the total consumption of leaded gasoline in Nige-
ria is 117,810 barrels per day (Table 1). Schwartz (1993) estimated 
that $17.2 billion dollars per year would be saved by a 1 µg/dL red-
uction in blood levels per year across the U.S. population. We used 
a similar approach to estimate the economic cost of lead exposure 
in Nigeria, but with modifications that capture issues specific to 
Nigeria and time differentials, including adjustments according to 
the consumer price index (CPI), and gross national income in pur-
chasing power parity (GNI-PPP) of 2.3% for the study period 
(Population Reference Bureau, 2006).  
 
 
RESULTS AND DISCUSSION 
 
Blood lead levels 
 
Blood lead levels measured in children of Otukpo are 
summarized in Table 2. The mean for all children was 9.4 
µg/dL (SD = 4.2, n = 306). The mean value for males 
(55% of the sample; Table 3) was not significantly higher 
than for females. The highest BLL measured was 31.8 
µg/dL, which is below the U.S. standard of 45 µg/dL for 
lead poisoning treatment with chelation therapy. The 
proportion of children having BLL above the USEPA 
action level of 10 µg/dL is more than one third.  
Figure 1 shows a comparison of BLL distribution 
among children residing in Otukpo with previous reports 
of blood lead levels for children in the more urbanized city 
of Kaduna and other distantly located cities (Nriagu et al., 
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Table 3. Summary of demographic characteristics in 






Age of Child 
1 Year 19.9 
2 Years 18.3 
3 Years 15.0 
4 Years 13.7 
5 Years 15.4 
6 Years 17.6 




Average Household Size 6.8 People 
Maternal Literacy 64.7 
Education Level Mother Father 
0-4 Years 61.5 55.6 
5-8 Years 17.9 21.6 
9-12 Years 18.2 15.0 
>12 Years 2.3 7.8 
Occupation Mother Father 
Self-Employed 54.6 30.9 
Professional 10.1 15.4 
Factory Worker 1.0 4.9 
Homemaker 14.1 0.0 
Farmer 13.4 27.8 
Other 13.1 18.6 
Years Child has Lived in Current Residence 
1 Year 28.1 
2 Years 20.9 
3 Years 15.0 
4 Years 12.4 





Table 3. Contd. 
 
6 Years 12.1 










Source of Drinking Water 
Pipes 29.7 





Time Spent Away From Home by Child 
0 Hours 84.3 
1 Hour 0.3 
2 Hours 0.7 
3 Hours 2.9 
4 Hours 2.6 
>4 Hours 9.4 
Children That Wash Hands 40.8 
Mothers that Cook/Store 





1997; Adeniyi and Anetor, 1999). The population of 
Kaduna is approximately 1.5 million people in 2002.  The 
mean BLL in Kaduna children ages 1 - 6 years old is 10.6 
µg dL-1 (± 3.8); with total atmospheric emissions of Pb in 
the region being 150 tons annually, and 97% of that 
exposure coming from leaded gasoline (Nriagu et al., 
1996; Obioh et al., 1988). 
Table 3 shows a summary of the Socio-Demographic 
data that was collected through the epidemiological 
survey. Almost 90% of the children were born in Otukpo, 
but less than half of the parents were indigenous. The 
average household size was approximately 7 individuals 
and most lived in attached compound houses constructed 
of cement bricks with groundwater wells being the source 
of drinking water. Mean BLL was significantly associated 
with household size, maternal literacy, parental occupa-
tion, home floor type, time spent outside the home, 
residential proximity to a ceramics shop, and by parental 
employment in a print shop (p<.05), but not with age, 
parental education, housing construction type or detach-
ment status, drinking  water,  and  frequency  of  hand-to- 




Table 4. Deaths (x1000) and DALYs (x1000) from all Pb-linked diseases for males and 
females, ages 0-14. 
 
Deaths, 0-14 DALYs, 0-14  
Pb-Disease Category male female male female 
Genito-Urinary Disease 16 13 710 541 
Prematurity* 384 384 2,295 2,295 
Dental Caries 0 0 129 127 
Nervous System Cancers 7 6 270 210 
Congenital Anomalies 32 33 2,455 2,628 
Hypertension** 2 2 66 69 
Cerebrovascular Disease 9 9 313 298 
Pb-Mild Mental Retardation (MMR) 0 0 2,463 2,414 
Low Birth Weight*** 262 234 9,827 8,873 
Sub-Saharan Africa (SSA) 712 681 18,528 17,455 
SSA, M & F 1,393 35,983 
Nigeria 121 116 3,150 2,967 
Nigeria, M & F 237 6,117 
 
*DALYs calculated using DISMOD with incidence rates from (Antilla et al., 1995). 





Table 5. Pb-linked burden of disease percentages (BDPb%). 
 
Deaths DALYs   
  male female male female 
PbBD% of SSA 2.42 2.75 1.82 2.04 
PbBD% of SSA, 0-14 4.57 5.31 2.97 3.34 
PbBD% of SSA, 0-14, m/f 4.90 3.14 
PbBD% of Nigeria 14.25 16.18 10.71 11.99 
PbBD% of Nigeria, 0-14 26.86 31.25 17.48 19.67 




mouth behavior (Ogunseitan and Smith, submitted).  
 
 
Lead-associated burden of disease estimates 
 
Table 4 shows the results for overall Deaths and DALYs 
by gender for children, ages 0-14, of Sub-Saharan Africa 
(SSA) and Nigeria. Table 5 shows the results by gender 
for lead-linked disease burden for children in Nigeria. The 
data are shown as a percentage of SSA burden, SSA 
childhood burden, Nigerian burden, and Nigerian child-
hood burden. Table 6 shows the medium estimate for 
DALYs of all nine disease burden categories by gender 
for children, ages 0-14, for both SSA and Nigeria. Also, 
the ORs that were found in the literature are shown. The 
three exposure categories are classified as low exposure 
(5-8 µg/dL), medium exposure (9-15 µg/dL), and high ex-
posure (>16 µg/dL). There is no OR for lead-attributed 
mild mental retardation (MMRPb) required, because by 
definition, 100% of MMRPb is due to lead exposure. Table 
7 shows the medium estimate of both the attributable risk 
and attributable burden for lead exposure across all three 
exposure categories for children, ages 0 - 14, in SSA and 
Nigeria. Also, the Pb-attributed burden of disease (BDPb) 
is shown as a percentage of the total Nigerian BD, and 
the total Nigerian childhood BD. Nigerian childhood BLLs 
of 5 - 8 µg/dL account for approximately 2.18% of the tot-
al Nigerian childhood burden, BLLs of 9 - 15 µg/dL acco-
unt for 7.50%, and BLLs >16 µg/dL account for 5.07%. 
Combined all lead exposure accounts for approximately 
14.74% of the total Nigerian childhood disease burden. 
 
 
Health costs of lead (Pb) exposure 
 
The estimates of childhood health costs of lead exposure 
are outlined in Table 8. The total costs are presented in 
millions of dollars. While all of the sub-categories (medi-
cal, compensatory education, lost earnings, IMR, and 
neonatal care) show significant health costs of Pb expos- 




Table 6. Dalys and odds ratios for 9 Pb-linked diseases (Medium estimate). 
 
Pb-Disease Category DALYs, 0-14 OR @ 3 PbB Levels* 
 male female total 5-8 9-15 >16 
Genito-Urinary Disease 710 541 1251 1.0 1.9 3.81 
Prematurity 2295 2295 4590 2.2 4.3 8.62,3 
Dental Caries 129 127 256 6.8 9.64 13.54 
Nervous System Cancers 270 210 480 2 5.55 11.05 
Congenital Anomalies 2455 2628 5083 1.0 1.6 3.26 
Hypertension 66 69 135 1.0 1.57 3 
Cerebrovascular Disease 313 298 611 2.28 4.58 6.88 
Pb-Mild Mental Retardation 2463 2414 4877 N/A N/A N/A 
Low Birth Weight 9827 8873 18700 1.2 2.4 4.79 
Total SSA 18528 17455 35983    
Total Nigeria 3150 2967 6117    
 
*BLLs are presented in ug/dL.  Not all the Odds ratios were available for all three blood lead levels in every disease 
category. Estimates were used in those cases. 1(Antilla et al., 1995) 2(Asien et al., 2000); 3(Khera et al., 1980); 
4(Gemmel et al., 2002); 5(Landrigan et al., 1976) 6(Kristensen et al., 1993) 7(Factor-Litvak et al., 1996) 8(Gomaa et 




Table 7. Attributable risks and attributable Burden for 9 Pb-linked diseases 
(Medium estimate) 
 
 AR for PbB Levels *AB for PbB Levels 
Pb-Disease Category 5-8 9-15 >16 5-8 9-15 >16 
Genito-Urinary Disease 0.0 33.5 21.9 0 419 274 
Prematurity 29.0 64.9 43.2 1,330 2,978 1,982 
Dental Caries 6.8 9.6 13.5 17 25 35 
Nervous System Cancers 25.4 71.6 50.0 122 344 240 
Congenital Anomalies 0.0 25.1 18.0 0 1,278 917 
Hypertension 0.0 21.9 16.7 0 30 23 
Cerebrovascular Disease 29.0 66.2 36.7 177 405 224 
Pb-Mild Mental Retardation 100.0 100.0 100.0 1,609 1,609 1,609 
Low Birth Weight 6.4 43.9 27.0 1,191 8,218 5,050 
Total SSA 4,446 15,306 10,353 
Total Nigeria 756 2,602 1,760 
% Nigeria BOD Attributable to Pb 1.40 4.80 3.25 
% Nigeria BOD, Attributable to Pb (0-14) 2.18 7.50 5.07 
 




ure, lost earnings and increased IMR appear to have the 
largest impact on overall cost. The total childhood health 
cost was estimated to be $10.3 billion ($238 million GNI-
PPP adjusted), or 29.8 billion naira annually for a 1 µg/dL 
increase in BLL.  Considering that the average BLL in 
Nigerian children is approximately 10 µg/dL, the cost of 
lead exposure could be ten times higher than what is 
reported here. Thus, if Nigeria is able to decrease 
national BLL average by 5 µg/dL, the country could gain 
more than $1 billion in savings annually from childhood 
health costs. 
Table 9 shows the results for the adult health costs of 
lead exposure. The total health costs are presented in 
millions of dollars. Mortality costs of hypertension–related 
deaths provide the driving force behind the bulk of the 
adult health costs, accounting for $6.6 billion out of $7 
billion (94%) estimated for total adult health costs. Table 
10 shows the estimates for the total health cost annually 
for the entire population. It also provides the annual per 
capita health cost of lead exposure, the annual health 
cost as a percentage of GNI-PPP, and the annual health 
cost as a percentage of the average per capita health ex- 




Table 8. Childhood health costs of lead exposure. 
 
Children Variable $(M) GNI-PPP Adjusted Million Naira 
Average blood lead concentration 9.8 ug/dL   
Number of children requiring 
chelation therapy 
160,909   





Total Medical Costs 309 7 888 
Number of children who receive 
education 
162,231   




  Total Compensatory Education 
Cost 
795 18 2,286 
Number children, age 6 3,515,600   
Increase in earnings of a 1 ug/dL 
reduction in BLL 




Total Earnings Lost 6,750 155 19,406 
IMR 75/1000   
1 ug/dL reduced maternal blood – 
IMR 
74.9/1000   
Value of statistical life 4,429,840   
Number of live births in Nigeria, 
2002 
5,192,000   






Total  IMR Cost 2,299.09 52.88 6,609.88 
# of NICU admissions 1,752,300   
Reduced NICU admissions 1,749,960   
Number of fewer NICU admissions 2,340   





Total Neonatal Cost 202.79 4.66 583.01 




expenditure.  All of these health cost figures are for a 1 
µg/dL change in BLL. The total health cost is presented 
as a low, medium, and high value. The low value was 
calculated by subtracting the cost of compensatory edu-
cation and NICU from the total. It is hypothesized that 
Nigeria could have significantly less compensatory edu-
cation than the United States for children who are aca-
demically challenged. Likewise, the frequency of children 
admitted into NICU in Nigeria could be much lower than 
the US. Based upon these assumptions, the low estimate 
for the health costs due to lead exposure is estimated to 
be approximately $377 million. The high value for health 
costs due to lead exposure was taken from Landrigan et 
al. (2002) who estimated that the health costs due to lead 
exposure for the cohort of children born in 2000 is app-
roximately $43.4 billion (USD, 1997). This estimate was 
adjusted using both the Consumer Price Index (CPI) and 
the GNI-PPP ratio between the US and Nigeria (2.3%). 
The resultant health cost estimate after allowing for these 
adjustments is approximately $1.15 billion. 
Cost of lead abatement 
 
Table 11 illustrates the cost of a lead abatement prog-
ram in Nigeria. The cost is a combination of four sub-
categories: the cost the refinery upgrades, the cost of a 
non-lead additive, the cost of unleaded gasoline, and the 
cost of TEL. These sub-category costs are presented in 
$/Liter. To calculate the overall cost of the abatement 
program, the cost of TEL is subtracted from the summed 
costs of refinery upgrades, non-lead additive, and un-
leaded gasoline. Using the national gasoline consump-
tion provided by the Department of Energy (DOE), the 
medium overall estimated cost of a lead abatement pro-
gram for Nigeria is approximately $194 million for the first 
year. This is approximately 48.5% of the health cost of a 
1 µg/dL increase in BLL per year µg/dL. 
The low estimate, using the low estimate cost of $0.01 
/L reported by the Organization for Economic Develop-
ment (OCED) for lead phase out is $76 million per year 
(11). The high estimate, using the high estimate cost of




Table 9. Adult health costs of lead exposure. 
 
Adults Variable $(M) GNI-PPP Adjusted Million Naira 
Medical costs 
Number of cases of hypertension 288,712 
Annual medical costs 812 
  
Hypertension 
Total Medical Cost 234.43 5.39 674.00 
Number of cases of heart attacks 1,454 
Medical costs 33,960 
  
Heart attacks 
Total Medical Cost 49.38 1.14 141.96 
Number of cases of stroke 591 
Annual medical costs 26,574 
  
Strokes 
  Total Medical Cost  15.71 0.36 45.15 
Lost wages 
Number of cases of hypertension 288,712 
Annual lost earnings 115.0 
  
Hypertension 
Total Earnings Lost 33.20 0.76 95.46 
Number of cases of heart attacks 1,454 
Annual lost earnings 31,000 
  
Heart Attacks 
Total Earnings Lost 45.07 1.04 129.59 
Number of cases of stroke 591 
Annual lost earnings 17,716 
  
Strokes 
Total Earnings Lost 10.47 0.24 30.10 
Number of deaths 1,500 
Value of statistical life 4,429,840 
   
Mortality 
Total Mortality Cost 6,644.76 152.83 19,103.69 














Total annual health cost to Nigeria of 1 µg/dL BPb  *16,391 377 47,124 
Annual per capita cost  126 2.90 362 
Annual cost as percentage of GNI-PPP 0.36% 0.36% 0.38% 
Annual cost as percentage of per capita health expenditures 14% 14% 14% 
Medium Estimate 
Total annual health cost to Nigeria of 1 µg/dL BPb  17,389 400 49,993 
Annual per capita cost  134 3.08 385 
Annual cost as percentage of GNI-PPP 0.38% 0.38% 0.38% 
Annual cost as percentage of per capita health expenditures 15% 15% 15% 
High Estimate 
Total annual health cost to Nigeria of 1 µg/dL BPb  **49,810 1,145 143,203 
Annual per capita cost  383 8.81 1,102 
Annual cost as percentage of GNI-PPP 1.10% 1.10% 0.38% 
Annual cost as percentage of per capita health expenditures 44% 44% 44% 
 
*Low estimate = Total health costs – cost of compensatory education and NICU. **High estimate = ($43.4 billion) (CPI, 
2003), (49). †Million Naira. 




Table 11. Cost of lead abatement in Nigeria. 
 
 Cost ($/liter) ‡Cons. (106 
l/year) 
Cost   (M$/yr 
1995) 
Cost   (M$/yr 
2003) 
Cost   
(†MN/yr, 2003) 
Unleaded Gasoline 0.01 6,837 68 82 10,250 
Non-Pb   Additive 0.01 6,837 68 82 10,250 
Refinery Retooling 0.006 6,495 39 47 5,875 
 
Abatement factors 
Tetraethyl   Lead (TEL) 0.002 6,837 14 17 2,125 
Domestic Gasoline 0.16 6,495 1,039 271 33,821 
Foreign Gasoline 0.16 342 55 66 8,250 
 
Gasoline source 
Total    Gasoline 0.16 6,837 1,094 1,313 164,148 
Low estimate 
 Total annual cost of abatement *75.6 24,250 
 Pb abatement cost / Pb health cost 0.189 0.189 
 Abatement as % of health cost 18.9% 18.9% 
Medium estimate 
 Total annual cost of abatement 194 24,250 
 Pb abatement cost / Pb health cost 0.485 0.485 
 Abatement as % of health cost 48.5% 48.5% 
High estimate 
 Total annual cost of abatement *227 24,250 
 Pb abatement cost / Pb health cost 0.567 0.567 
 Abatement as % of health cost 56.7% 56.7% 
 





$0.03/L reported by OECD, is $227 million per year 
(OECD, 1999).  
In conclusion, we have shown that lead exposure 
remains a major health risk factor in all Nigeria commu-
nities, both rural and urban. The most important – and 
controllable – source of exposure is leaded automobile 
fuels. Arguments based on the enormous costs to society 
of switching to unleaded fuels are weak in the face of 
counterarguments based on the even more astounding 
health care and special educational costs associated with 
lead exposure. In the presence of alternative renewable 
fuels such as ethanol (Thomas and Kwong, 2000), the 
removal of lead from all fuels in Nigeria – and all coun-
tries in sub-Saharan Africa – should not be delayed a sin-
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